(IAC) IAC - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US44891N2080
Stock:
Total Rating 36
Risk 69
Buy Signal 0.71
| Risk 5d forecast | |
|---|---|
| Volatility | 35.8% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -18.57 |
| Character TTM | |
|---|---|
| Beta | 0.922 |
| Beta Downside | 0.861 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.81% |
| CAGR/Max DD | -0.10 |
EPS (Earnings per Share)
Revenue
Description: IAC IAC
IAC Inc., together with its subsidiaries, operates as a media and internet company worldwide. The company publishes original and engaging digital content in the form of articles, illustrations, and videos and images; and magazines related to women and lifestyle under the People, Better Homes & Gardens, Verywell, FOOD & WINE, The Spruce, allrecipes, BYRDIE, REAL SIMPLE, Investopedia, and Southern Living brands. It also operates a digital marketplace that connects home service professionals with consumers for repairing, remodeling, cleaning, landscaping, maintenance, and enhancement services under the Angi Ads and Leads, and Angi Services brands. In addition, the company operates websites that offers general search services and information, including Ask.com, a search site with a variety of fresh and contemporary content; Reference.com that offers content across select vertical categories; Consumersearch.com, which offers content designed to simplify the product research process; and Shopping.net, a vertical shopping search site, as well as offers direct-to-consumer downloadable desktop applications. Further, it provides Care.com, an online destination for families to connect with caregivers for their children, aging parents, pets, and homes under the Care For Business and HomePay brands; a platform to connect healthcare professionals with job opportunities under the Vivian Health name; The Daily Beast, a website dedicated to news, commentary, culture, and entertainment that publishes original reporting and opinion; and production and producer services for feature films for sale and distribution through theatrical releases and video-on-demand services under the IAC Films name. The company was formerly known as IAC/InterActiveCorp. The company is headquartered in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -104.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -2.79 > 1.0 |
| NWC/Revenue: 41.11% < 20% (prev 55.32%; Δ -14.21% < -1%) |
| CFO/TA 0.01 > 3% & CFO 64.0m > Net Income -104.0m |
| Net Debt (465.6m) to EBITDA (168.7m): 2.76 < 3 |
| Current Ratio: 2.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (77.6m) vs 12m ago -6.82% < -2% |
| Gross Margin: 64.86% > 18% (prev 0.65%; Δ 6421 % > 0.5%) |
| Asset Turnover: 28.70% > 50% (prev 30.27%; Δ -1.57% > 0%) |
| Interest Coverage Ratio: 0.32 > 6 (EBITDA TTM 168.7m / Interest Expense TTM 120.0m) |
Altman Z'' 0.35
| A: 0.14 (Total Current Assets 1.54b - Total Current Liabilities 560.9m) / Total Assets 7.13b |
| B: -0.09 (Retained Earnings -643.0m / Total Assets 7.13b) |
| C: 0.00 (EBIT TTM 38.1m / Avg Total Assets 8.34b) |
| D: -0.28 (Book Value of Equity -654.8m / Total Liabilities 2.34b) |
| Altman-Z'' Score: 0.35 = B |
Beneish M -3.10
| DSRI: 1.04 (Receivables 448.8m/519.7m, Revenue 2.39b/2.89b) |
| GMI: 1.00 (GM 64.86% / 64.75%) |
| AQI: 1.06 (AQ_t 0.74 / AQ_t-1 0.70) |
| SGI: 0.83 (Revenue 2.39b / 2.89b) |
| TATA: -0.02 (NI -104.0m - CFO 64.0m) / TA 7.13b) |
| Beneish M-Score: -3.10 (Cap -4..+1) = AA |
What is the price of IAC shares?
As of February 26, 2026, the stock is trading at USD 37.11 with a total of 946,062 shares traded.
Over the past week, the price has changed by +2.16%, over one month by -6.65%, over three months by +7.96% and over the past year by -1.29%.
Over the past week, the price has changed by +2.16%, over one month by -6.65%, over three months by +7.96% and over the past year by -1.29%.
Is IAC a buy, sell or hold?
IAC has received a consensus analysts rating of 4.29.
Therefore, it is recommended to buy IAC.
- StrongBuy: 7
- Buy: 4
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IAC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.3 | 27.5% |
| Analysts Target Price | 47.3 | 27.5% |
IAC Fundamental Data Overview February 21, 2026
P/E Forward = 36.7647
P/S = 1.1819
P/B = 0.5965
P/EG = 13.6232
Revenue TTM = 2.39b USD
EBIT TTM = 38.1m USD
EBITDA TTM = 168.7m USD
Long Term Debt = 1.41b USD (from longTermDebt, two quarters ago)
Short Term Debt = 24.5m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 465.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.29b USD (2.83b + Debt 1.43b - CCE 960.2m)
Interest Coverage Ratio = 0.32 (Ebit TTM 38.1m / Interest Expense TTM 120.0m)
EV/FCF = 73.48x (Enterprise Value 3.29b / FCF TTM 44.8m)
FCF Yield = 1.36% (FCF TTM 44.8m / Enterprise Value 3.29b)
FCF Margin = 1.87% (FCF TTM 44.8m / Revenue TTM 2.39b)
Net Margin = -4.35% (Net Income TTM -104.0m / Revenue TTM 2.39b)
Gross Margin = 64.86% ((Revenue TTM 2.39b - Cost of Revenue TTM 841.0m) / Revenue TTM)
Gross Margin QoQ = 64.97% (prev 64.83%)
Tobins Q-Ratio = 0.46 (Enterprise Value 3.29b / Total Assets 7.13b)
Interest Expense / Debt = 1.89% (Interest Expense 26.9m / Debt 1.43b)
Taxrate = 21.0% (US default 21%)
NOPAT = 30.1m (EBIT 38.1m * (1 - 21.00%))
Current Ratio = 2.75 (Total Current Assets 1.54b / Total Current Liabilities 560.9m)
Debt / Equity = 0.30 (Debt 1.43b / totalStockholderEquity, last quarter 4.73b)
Debt / EBITDA = 2.76 (Net Debt 465.6m / EBITDA 168.7m)
Debt / FCF = 10.39 (Net Debt 465.6m / FCF TTM 44.8m)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.25% (Net Income -104.0m / Total Assets 7.13b)
RoE = -2.17% (Net Income TTM -104.0m / Total Stockholder Equity 4.79b)
RoCE = 0.62% (EBIT 38.1m / Capital Employed (Equity 4.79b + L.T.Debt 1.41b))
RoIC = 0.48% (NOPAT 30.1m / Invested Capital 6.25b)
WACC = 6.69% (E(2.83b)/V(4.25b) * Re(9.31%) + D(1.43b)/V(4.25b) * Rd(1.89%) * (1-Tc(0.21)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.42%
[DCF] Terminal Value 76.60% ; FCFF base≈157.5m ; Y1≈103.4m ; Y5≈47.2m
[DCF] Fair Price = 10.41 (EV 1.21b - Net Debt 465.6m = Equity 744.2m / Shares 71.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 28.89 | EPS CAGR: 17.35% | SUE: -1.26 | # QB: 0
Revenue Correlation: -87.59 | Revenue CAGR: -17.44% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.28 | Chg7d=-0.123 | Chg30d=-0.123 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=0.46 | Chg7d=-0.169 | Chg30d=-0.169 | Revisions Net=-5 | Growth EPS=+135.3% | Growth Revenue=-4.8%
EPS next Year (2027-12-31): EPS=1.15 | Chg7d=+0.025 | Chg30d=+0.025 | Revisions Net=-2 | Growth EPS=+149.8% | Growth Revenue=+0.7%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)
P/S = 1.1819
P/B = 0.5965
P/EG = 13.6232
Revenue TTM = 2.39b USD
EBIT TTM = 38.1m USD
EBITDA TTM = 168.7m USD
Long Term Debt = 1.41b USD (from longTermDebt, two quarters ago)
Short Term Debt = 24.5m USD (from shortTermDebt, last quarter)
Debt = 1.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 465.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.29b USD (2.83b + Debt 1.43b - CCE 960.2m)
Interest Coverage Ratio = 0.32 (Ebit TTM 38.1m / Interest Expense TTM 120.0m)
EV/FCF = 73.48x (Enterprise Value 3.29b / FCF TTM 44.8m)
FCF Yield = 1.36% (FCF TTM 44.8m / Enterprise Value 3.29b)
FCF Margin = 1.87% (FCF TTM 44.8m / Revenue TTM 2.39b)
Net Margin = -4.35% (Net Income TTM -104.0m / Revenue TTM 2.39b)
Gross Margin = 64.86% ((Revenue TTM 2.39b - Cost of Revenue TTM 841.0m) / Revenue TTM)
Gross Margin QoQ = 64.97% (prev 64.83%)
Tobins Q-Ratio = 0.46 (Enterprise Value 3.29b / Total Assets 7.13b)
Interest Expense / Debt = 1.89% (Interest Expense 26.9m / Debt 1.43b)
Taxrate = 21.0% (US default 21%)
NOPAT = 30.1m (EBIT 38.1m * (1 - 21.00%))
Current Ratio = 2.75 (Total Current Assets 1.54b / Total Current Liabilities 560.9m)
Debt / Equity = 0.30 (Debt 1.43b / totalStockholderEquity, last quarter 4.73b)
Debt / EBITDA = 2.76 (Net Debt 465.6m / EBITDA 168.7m)
Debt / FCF = 10.39 (Net Debt 465.6m / FCF TTM 44.8m)
Total Stockholder Equity = 4.79b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.25% (Net Income -104.0m / Total Assets 7.13b)
RoE = -2.17% (Net Income TTM -104.0m / Total Stockholder Equity 4.79b)
RoCE = 0.62% (EBIT 38.1m / Capital Employed (Equity 4.79b + L.T.Debt 1.41b))
RoIC = 0.48% (NOPAT 30.1m / Invested Capital 6.25b)
WACC = 6.69% (E(2.83b)/V(4.25b) * Re(9.31%) + D(1.43b)/V(4.25b) * Rd(1.89%) * (1-Tc(0.21)))
Discount Rate = 9.31% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -6.42%
[DCF] Terminal Value 76.60% ; FCFF base≈157.5m ; Y1≈103.4m ; Y5≈47.2m
[DCF] Fair Price = 10.41 (EV 1.21b - Net Debt 465.6m = Equity 744.2m / Shares 71.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 28.89 | EPS CAGR: 17.35% | SUE: -1.26 | # QB: 0
Revenue Correlation: -87.59 | Revenue CAGR: -17.44% | SUE: 0.03 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.28 | Chg7d=-0.123 | Chg30d=-0.123 | Revisions Net=-2 | Analysts=8
EPS current Year (2026-12-31): EPS=0.46 | Chg7d=-0.169 | Chg30d=-0.169 | Revisions Net=-5 | Growth EPS=+135.3% | Growth Revenue=-4.8%
EPS next Year (2027-12-31): EPS=1.15 | Chg7d=+0.025 | Chg30d=+0.025 | Revisions Net=-2 | Growth EPS=+149.8% | Growth Revenue=+0.7%
[Analyst] Revisions Ratio: -0.33 (2 Up / 4 Down within 30d for Next Quarter)